Candel Therapeutics: A Low-Price Oncolytic Virus Plays Further Along Than You Think

Core Insights - Candel Therapeutics is a biotech company focused on developing viral therapies for treating solid tumors, aiming to succeed where others have previously failed in this area [1] Company Overview - Candel Therapeutics is listed on NASDAQ under the ticker CADL and specializes in viral therapy development [1] Industry Context - The biotech industry faces challenges in effectively treating solid tumors, with many companies having struggled to find successful solutions [1]